Mammalian Adaptation in the PB2 Gene of Avian H5N1 Influenza Virus

ABSTRACT The substitution of glutamic acid (E) for lysine (K) at position 627 of the PB2 protein of avian H5N1 viruses has been identified as a virulence and host range determinant for infection of mammals. Here, we report that the E-to-K host-adaptive mutation in the PB2 gene appeared from day 4 and 5 along the respiratory tracts of mice and was complete by day 6 postinoculation. This mutation correlated with efficient replication of the virus in mice.

[1]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[2]  G. Gabriel,et al.  Human-like PB2 627K Influenza Virus Polymerase Activity Is Regulated by Importin-α1 and -α7 , 2012, PLoS pathogens.

[3]  Michael G. Katze,et al.  A Single-Amino-Acid Substitution in a Polymerase Protein of an H5N1 Influenza Virus Is Associated with Systemic Infection and Impaired T-Cell Activation in Mice , 2009, Journal of Virology.

[4]  Lior Pachter,et al.  Fast Statistical Alignment , 2009, PLoS Comput. Biol..

[5]  Y. Kawaoka,et al.  Selection of H5N1 Influenza Virus PB2 during Replication in Humans , 2009, Journal of Virology.

[6]  John Steel,et al.  Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N , 2009, PLoS pathogens.

[7]  Jin Hyun Kim,et al.  Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice , 2007, PLoS pathogens.

[8]  Ron A M Fouchier,et al.  The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. , 2007, The Journal of infectious diseases.

[9]  M. Okamatsu,et al.  Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice. , 2006, The Journal of general virology.

[10]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[11]  H. Klenk,et al.  The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[13]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[14]  M. Kiso,et al.  Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. , 2005, Virology.

[15]  S. Salzberg,et al.  Versatile and open software for comparing large genomes , 2004, Genome Biology.

[16]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[17]  P. Massin,et al.  Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.

[18]  P. Massin,et al.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. , 2000, The Journal of general virology.

[19]  John J. Treanor,et al.  Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .

[20]  P. Ward,et al.  Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. , 2000, JAMA.

[21]  B. Murphy,et al.  Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation , 1993, Journal of virology.